There are too few skilled health care workers to provide reliable delivery and administration of these life-saving therapies.

Drug patents are under attack, blamed for high AIDS drug prices that deny life-saving therapy to millions of people in developing countries.

In emergency surgery to repair blood vessels and organs torn in accidents, for example, transfusions are often a life-saving therapy to which there is no alternative.

Was it right to withhold potentially life-saving therapy because two doctors drew an arbitrary line in the sand?

More people today have access to life-saving antiretroviral therapy for HIV/AIDS than ever before.

Are the small number of experiences enough to provide sufficient perspective for most people to judge the benefits and risks of potentially life-saving therapies before refusing them?

Proponents of the fast-track system argue it is necessary to bring life-saving therapies to patients who desperately need them.

Speeding up enrollment can accelerate the discovery and use of cost-saving, life-saving new therapies.

Only a fraction of children living with HIV receive life-saving anti-retroviral therapy (ART).

I am determined to ensure that this new directive will not unwillingly contribute to shortages of life-saving therapies.